CAS 129623-01-4

L-Tryptophanamide,5-oxo-L-prolyl-L-alanyl-L-a-aspartyl-L-prolyl-L-asparaginyl-L-lysyl-L-phenylalanyl-L-tyrosyl-(aS,5S)-a-(2-methylpropyl)-6-oxo-1,7-diazaspiro[4.4]nonane-7-acetyl-

Description:

L-Tryptophanamide, with the CAS number 129623-01-4, is a complex organic compound characterized by its intricate structure, which includes multiple amino acid residues and a spirocyclic framework. This substance features a combination of functional groups typical of peptides and amides, contributing to its potential biological activity. The presence of tryptophan, a precursor to serotonin, suggests possible neuroactive properties. The spirocyclic structure may impart unique conformational characteristics, influencing its interaction with biological targets. Additionally, the compound's multiple chiral centers indicate that it exists in specific stereoisomeric forms, which can significantly affect its pharmacological profile. Overall, L-Tryptophanamide is of interest in medicinal chemistry and biochemistry, particularly in the context of drug design and development, due to its potential roles in modulating biological processes. However, detailed studies on its specific properties, mechanisms of action, and therapeutic applications would be necessary to fully understand its significance in these fields.

Formula: C₆₉H₉₁N₁₅O₁₆

Synonyms:

• Physalemin,9-deglycine-10-[(5S)-6-oxo-L-a-(2-methylpropyl)-1,7-diazaspiro[4.4]nonane-7-aceticacid]-11-L-tryptophanamide-
• 1,7-Diazaspiro[4.4]nonane, physalemin deriv.
• Gr82334

GR 82334

CAS: 129623-01-4

Tachykinin NK1 receptor antagonist.

Formula: C₆₉H₉₁N₁₅O₁₆

Purity: 98%

Color and Shape: Solid

Molecular weight: 1386.57

Ref: TM-TP2024

GR 82334

CAS: 129623-01-4

Formula: C₆₉H₉₁N₁₅O₁₆

Molecular weight: 1386.55

Ref: 7W-GK0958

GR 82334

CAS: 129623-01-4

GR 82334 is an experimental drug that acts as a 5-HT4 receptor agonist. It has been shown to be effective in animal experiments and in treating symptoms of autoimmune diseases. GR 82334 also has an inhibitory effect on platelet aggregation, which may be due to its ability to act as an anti-platelet agent by activating the 5-HT4 receptor. GR 82334 is also a diagnostic tool for Parkinson's disease, because it can induce Parkinsonian symptoms in animals and humans. This drug is being researched for other potential uses, such as its potential as a treatment for neurokinin-1 receptor (NK1R) related disorders such as migraine headaches.

Formula: C₆₉H₉₁N₁₅O₁₆

Purity: Min. 95%

Molecular weight: 1,386.6 g/mol

Ref: 3D-EFA62301